NeoGraph Analytics
Medical ImagingNorth America2023 – 2032

Global United States Medical Imaging AI Market Analysis, Opportunities and Forecast 2024-2032

The United States Medical Imaging AI market was valued at $1.12B in 2023, projected to reach $10.0B by 2032 at a 27.5% CAGR.

Revenue, 2023

$1.1B

Forecast, 2032

$10.0B

CAGR, 2024-2032

27.5%

Report Coverage

North America

Code: united-states-medical-imaging-ai-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Executive Summary

The United States Medical Imaging AI market, valued at USD 1.12 billion in 2023, is projected to reach USD 10.0 billion by 2032, growing at a 27.5% CAGR. Driven by radiologist shortages, rising imaging volumes, and accelerating FDA approvals, the market presents significant investment opportunities across CT, MRI, and radiology application segments.

02

Key Highlights

1

US medical imaging AI market valued at USD 1.12 billion in 2023, forecast to reach USD 10.0 billion by 2032.

2

CT scan and radiology segments dominate, collectively commanding over 53% of total market revenue share in 2023.

3

Hospitals remain the primary end users, accounting for 45% of market adoption across the United States.

4

North America holds 40% global market share with the US representing 38% of the regional market.

5

27.5% CAGR driven by FDA approvals, radiologist shortages, and expanding AI diagnostic applications nationwide.

03

Market Overview

Market Context

The US medical imaging AI market is in a high-growth phase, propelled by increasing imaging volumes, radiologist shortages, and accelerating regulatory approvals. Cloud-based AI platforms and generative AI tools are reshaping diagnostic workflows across hospitals and imaging centers.

The US medical imaging AI market is experiencing rapid growth, fueled by AI integration in radiology workflows, rising diagnostic demand, and expanding FDA clearances. CT and oncology segments lead adoption, with hospitals as primary end users.

Market Stage

High growth

Adoption Level

Growing

Key Trends

Rapid adoption of generative AI for medical image synthesis and annotationCloud-based AI platforms gaining traction over on-premise deploymentsIncreasing FDA clearances for AI-assisted diagnostic imaging toolsGrowing focus on AI-driven early cancer detection and screening
04

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 27.5%

Base Year (2023)

$1.1B

Forecast (2032)

$10.0B

CAGR (2024-2032)

27.5%

Market size by year, 2024-2032, in USD Billion.
YearMarket size ($ Billion)
2023Base year$1.12B
2024$1.43B
2025$1.82B
2026$2.32B
2027$2.96B
2028$3.77B
2029$4.81B
2030$6.13B
2031$7.82B
2032$9.97B
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Forecast Analysis

The market is projected to grow from USD 1.12 billion in 2023 to USD 10.0 billion by 2032 at a 27.5% CAGR. CT scan and radiology applications will continue leading adoption, while cardiology and neurology segments present emerging high-growth opportunities.

Regional Market Analysis
Market share and growth rate by region
Regional market analysis — market share, growth rate and largest market by region.
RegionMarket shareGrowth rateLargest market
North America40.0%27.5%United States
Europe26.0%24.2%Germany
Asia Pacific22.0%32.1%China
Rest of World12.0%22.8%Brazil

North America

#1
Share: 40.0%CAGR: 27.5%

Largest market: United States

Europe

#2
Share: 26.0%CAGR: 24.2%

Largest market: Germany

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
05

Market Dynamics

  • Rising radiologist shortage and increasing diagnostic imaging volumes
  • FDA approvals accelerating AI-powered medical imaging software adoption
  • Growing integration of AI in oncology and cardiovascular diagnostics
06

Market Segmentation

By Modality
Market share distribution across 6 segments
By Modality — market share by segment, in percent.
SegmentShare
CT ScanCT scan leads the market due to high AI adoption in detecting pulmonary and abdominal conditions.25.0%
MRIMRI segment grows rapidly with AI-driven neurology and musculoskeletal imaging applications.22.0%
X-RayX-ray AI solutions gain traction in emergency departments and primary care screening.18.0%
UltrasoundUltrasound AI adoption rises in obstetrics, cardiology, and point-of-care settings.15.0%
PET ScanPET scan AI enhances oncology staging and treatment response monitoring.12.0%
MammographyMammography AI improves breast cancer screening accuracy and radiologist efficiency.8.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
By Application
Market share distribution across 6 segments
By Application — market share by segment, in percent.
SegmentShare
RadiologyRadiology dominates as AI automates image reading and triage workflows across hospitals.28.0%
OncologyOncology applications grow with AI-driven tumor detection, segmentation, and treatment planning.24.0%
CardiologyCardiology AI enables faster diagnosis of cardiac conditions from CT and MRI scans.18.0%
NeurologyNeurology AI supports stroke detection, brain tumor analysis, and neurodegenerative disease screening.15.0%
OrthopedicsOrthopedic AI assists in fracture detection and musculoskeletal imaging interpretation.10.0%
OthersOther applications include ophthalmology, dermatology, and abdominal imaging AI tools.5.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.

By End User

  • Hospitals
  • Diagnostic Centers
  • Research Institutes
  • Clinics
07

Regional Analysis

1

North America

Lead: United States
CAGR: 27.5%Share: 40.0%

North America leads globally driven by advanced healthcare infrastructure and strong AI adoption.

2

Europe

Lead: Germany
CAGR: 24.2%Share: 26.0%

Europe grows steadily with increasing EU regulatory approvals and digital health investments.

3

Asia Pacific

Lead: China
CAGR: 32.1%Share: 22.0%

Asia Pacific exhibits the fastest growth, fueled by expanding healthcare access and AI investments.

4

Rest of World

Lead: Brazil
CAGR: 22.8%Share: 12.0%

Emerging markets in Latin America and Middle East show growing AI imaging adoption.

Country-Level Analysis

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Market share and growth rate by country
CountryShareGrowth
United States
38.0%
+28.5%
Germany
14.0%
+24.2%
China
18.0%
+32.1%
08

Competitive Landscape

A

Aidoc

Israel

Leader150M

Leading provider of AI-powered radiology solutions with broad FDA clearances across multiple imaging modalities.

Specialized AI radiology company delivering FDA-cleared algorithms for critical finding detection across multiple imaging modalities.

V

Viz.ai

United States

Challenger100M

Fast-growing AI company specializing in stroke and vascular detection with rapid US hospital network expansion.

AI-driven care coordination platform focused on stroke and vascular disease detection with rapid clinical workflow integration.

A

Arterys

United States

Follower

Cloud-native medical imaging AI platform offering FDA-cleared cardiac and lung imaging solutions.

Also profiled

S

Siemens Healthineers

22B

Global leader in medical imaging equipment integrating AI-powered diagnostic solutions across CT, MRI, and X-ray platforms.

09

Recent Developments

25
2025Aidoc

Received FDA clearance for AI-powered chest X-ray analysis platform expanding thoracic condition detection capabilities.

24
2024Viz.ai

Expanded AI stroke detection platform to over 1,000 US hospitals strengthening nationwide care coordination networks.

10

Regulatory Landscape

FDA AI/ML-Based Software as a Medical Device (SaMD) Action PlanHIPAA Compliance for AI-Driven Medical Imaging Data
11

Research Methodology

Primary research

  • Expert interviews
  • Surveys

Secondary research

  • Industry reports
  • Company financials

Validation: Triangulation method

12

Strategic Takeaways

Investors

The market offers high-growth potential driven by regulatory approvals, increasing radiology workloads, and expanding AI integration in diagnostic imaging workflows nationwide.

Operators

Adopt scalable AI platforms focusing on CT and radiology applications to capture growing demand from hospitals and diagnostic centers.

Policymakers

Develop standardized AI validation protocols to address regulatory uncertainty and accelerate safe clinical deployment.

13

Frequently Asked Questions

Reports in the same field, each with its base-year figure and the growth rate it is published at.